The Enterprise Value as of September 2024 (TTM) for Vallon Pharmaceuticals, Inc. (VLON) is -6212000.00

According to Vallon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6212000.00. This represents a change of -100.46% compared to the average of 1.36B of the last 4 quarters.

Vallon Pharmaceuticals, Inc. (VLON) Historical Enterprise Value (quarterly & annually)

How has VLON Enterprise Value performed in the past?

The mean historical Enterprise Value of Vallon Pharmaceuticals, Inc. over the last ten years is 29.73M. The current -6212000.00 Enterprise Value has changed -2189.57% with respect to the historical average. Over the past ten years (40 quarters), VLON's Enterprise Value was at its highest in in the December 2023 quarter at 1.99B. The Enterprise Value was at its lowest in in the September 2022 quarter at -1278316.54.

Vallon Pharmaceuticals, Inc. (VLON) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vallon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vallon Pharmaceuticals, Inc. (VLON) Average Enterprise Value

How has VLON Enterprise Value performed in the past?

The current Enterprise Value of Vallon Pharmaceuticals, Inc. (VLON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vallon Pharmaceuticals, Inc. (VLON) Enterprise Value vs. Peers

How is VLON’s Enterprise Value compared to its peers?

Vallon Pharmaceuticals, Inc.’s Enterprise Value is less than Ikena Oncology, Inc. (46.38M), less than Foghorn Therapeutics Inc. (318.59M), greater than Werewolf Therapeutics, Inc. (-10348556.00), less than Clene Inc. (49.30M), less than Immunome, Inc. (650.58M), less than Zura Bio Limited (42.42M), less than Phio Pharmaceuticals Corp. (-2451521.00), less than Sonnet BioTherapeutics Holdings, Inc. (1.13M), less than 180 Life Sciences Corp. (1.19M), less than Cardio Diagnostics Holdings, Inc. (6.50M), greater than Palisade Bio, Inc. (-6597681.00), less than Quoin Pharmaceuticals, Ltd. (218.65K), greater than Revelation Biosciences, Inc. (-10643144.00), less than Virax Biolabs Group Limited (11.88M), less than Unicycive Therapeutics, Inc. (38.45M), less than ContraFect Corporation (-1135867.00), greater than Allarity Therapeutics, Inc. (-10898430.00), less than CNS Pharmaceuticals, Inc. (3.24M), less than Windtree Therapeutics, Inc. (3.72M), less than Panbela Therapeutics, Inc. (5.88M),

Build a custom stock screener for Vallon Pharmaceuticals, Inc. (VLON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vallon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vallon Pharmaceuticals, Inc. (VLON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vallon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.